These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28428567)

  • 1. Novel oral anticoagulants and exodontia: the evidence.
    Nathwani S; Wanis C
    Br Dent J; 2017 Apr; 222(8):623-628. PubMed ID: 28428567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exodontia in dual antiplatelet therapy: the evidence.
    Nathwani S; Martin K
    Br Dent J; 2016 Mar; 220(5):235-8. PubMed ID: 26964594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.
    Sivolella S; De Biagi M; Brunello G; Berengo M; Pengo V
    Odontology; 2015 Sep; 103(3):258-63. PubMed ID: 25656043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants].
    Löser C; Nast A; Zeymer U
    Hautarzt; 2019 Nov; 70(11):850-853. PubMed ID: 31560079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery.
    Johnston S
    Int J Oral Maxillofac Surg; 2016 May; 45(5):618-30. PubMed ID: 26774397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB; Swanson MT
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
    Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
    Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
    Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
    Coleman CM; Khalaf S; Mould S; Wazni O; Kanj M; Saliba W; Cantillon D
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):731-7. PubMed ID: 25721150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications.
    Costantinides F; Rizzo R; Pascazio L; Maglione M
    BMC Oral Health; 2016 Jan; 16():5. PubMed ID: 26822674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Hernandez I; Zhang Y; Saba S
    Am J Cardiol; 2017 Nov; 120(10):1813-1819. PubMed ID: 28864318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using new oral anticoagulants in patients undergoing major orthopedic surgery.
    Bass AR
    Curr Rheumatol Rep; 2015 Apr; 17(4):25. PubMed ID: 25854486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study.
    Antia C; Hone N; Gloster H
    J Am Acad Dermatol; 2017 Nov; 77(5):967-968. PubMed ID: 29029905
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and Efficacy of Novel Oral Anticoagulants vs Low Molecular Weight Heparin for Thromboprophylaxis in Large-Volume Liposuction and Body Contouring Procedures.
    Morales R; Ruff E; Patronella C; Mentz H; Newall G; Hustak KL; Fortes P; Bush A
    Aesthet Surg J; 2016 Apr; 36(4):440-9. PubMed ID: 26961988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative management of patients on new oral anticoagulants.
    Lai A; Davidson N; Galloway SW; Thachil J
    Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of bleeding complications due to oral anticoagulant drugs].
    Riess H
    Laryngorhinootologie; 2015 Oct; 94(10):697-709. PubMed ID: 26468622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.